Shares of Arena Pharmaceuticals rose 2.92% to $67.22 at 14:05 EST on Friday, after two successive sessions in a row of losses. The Nasdaq Stock Market is jumping 0.56% to $12,446.80, following yesterday’s upward trend, on what so far seems, a somewhat positive trend trading session today.

Arena Pharmaceuticals’s last close was $65.31, 34.17% under its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the present quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals’s Stock Top and Bottom Yearly Value

Arena Pharmaceuticals’s stock is valued at $67.22 at 14:05 EST, way below its 52-week high of $90.19 and way higher than its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s worth is way under its 50-day moving average of $74.74 and below its 200-day moving average of $68.54.


Please enter your comment!
Please enter your name here